Recent reports have suggested that PI3K/Akt/mTOR pathway is often activated in various forms of lung cancer and that this pathway is considered to be important for cancer cells' survival, proliferation, angiogenesis and resistance to chemotherapy. This evidence concerns the gene AKT1 and lung carcinoma.